000 -LEADER |
fixed length control field |
01514cam a22003734a 4500 |
001 - CONTROL NUMBER |
control field |
15410065 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20130306094613.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
080811s2009 njua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2008035472 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780470195109 (cloth) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
047019510X |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DNLM)101481149 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DNLM/DLC |
Transcribing agency |
DLC |
Modifying agency |
DLC |
-- |
EG-CaHUL |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM301.25 |
Item number |
.N5 2009 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Edition number |
22 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Ng, Rick. |
245 10 - TITLE STATEMENT |
Title |
Drugs : |
Remainder of title |
from discovery to approval / |
Statement of responsibility, etc |
Rick Ng. |
250 ## - EDITION STATEMENT |
Edition statement |
2nd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Hoboken, N.J. : |
Name of publisher, distributor, etc |
John Wiley & Sons, |
Date of publication, distribution, etc |
c2009. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiii, 466 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Drug discovery : targets and receptors -- Drug discovery : small molecule drugs -- Drug discovery : large molecule drugs -- Drug development and preclinical studies -- Clinical trial -- Regulatory authorities -- Regulatory applications -- Good manufacturing practice : regulatory requirements -- Good manufacturing practice : drug manufacturing -- Future perspectives. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug development. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Technology, Pharmaceutical. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chemistry, Pharmaceutical. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical Trials as Topic |
General subdivision |
methods. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Approval |
General subdivision |
legislation & jurisprudence. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Approval |
General subdivision |
methods. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Design. |
856 41 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Table of contents only |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip0825/2008035472.html">http://www.loc.gov/catdir/toc/ecip0825/2008035472.html</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Books |